Baseline characteristics: GZL consensus confirmed cases
Characteristics . | n (%) . |
---|---|
Patient characteristics | |
Median age | 37 y (range, 19-72 y) |
Sex | |
Male | 17 (62) |
Female | 9 (38) |
Performance status | |
0-1 | 24 (88) |
2-4 | 2 (8) |
NA | 1 (4) |
B symptoms | |
Yes | 9 (35) |
No | 13 (50) |
NA | 4 (15) |
Albumin | |
Normal | 7 (27) |
Low | 14 (54) |
NA | 5 (19) |
Hemoglobin | |
Decreased | 15 (58) |
Normal | 10 (38) |
NA | 1 (4) |
LDH | |
Normal | 9 (35) |
Elevated | 15 (58) |
NA | 2 (7) |
Disease characteristics | |
Mediastinal involvement/disease | 18 (69) |
Bone marrow involvement | |
Absent | 25 (96) |
Present | 0 (0) |
NA | 1 (4) |
Extranodal sites present | |
≤1 | 25 (96) |
>1 | 0 (0) |
NA | 1 (4) |
Stage | |
I/II | 17 (65) |
III/IV | 8 (31) |
NA | 1 (4) |
Bulky disease | |
Yes | 8 (31) |
No | 16 (62) |
NA | 2 (7) |
IPI | |
0-2 | 17 (65) |
3-5 | 5 (19) |
NA | 4 (16) |
IPS | |
0-1 | 9 (35) |
2-3 | 9 (35) |
4-6 | 2 (7) |
NA | 6 (23) |
Characteristics . | n (%) . |
---|---|
Patient characteristics | |
Median age | 37 y (range, 19-72 y) |
Sex | |
Male | 17 (62) |
Female | 9 (38) |
Performance status | |
0-1 | 24 (88) |
2-4 | 2 (8) |
NA | 1 (4) |
B symptoms | |
Yes | 9 (35) |
No | 13 (50) |
NA | 4 (15) |
Albumin | |
Normal | 7 (27) |
Low | 14 (54) |
NA | 5 (19) |
Hemoglobin | |
Decreased | 15 (58) |
Normal | 10 (38) |
NA | 1 (4) |
LDH | |
Normal | 9 (35) |
Elevated | 15 (58) |
NA | 2 (7) |
Disease characteristics | |
Mediastinal involvement/disease | 18 (69) |
Bone marrow involvement | |
Absent | 25 (96) |
Present | 0 (0) |
NA | 1 (4) |
Extranodal sites present | |
≤1 | 25 (96) |
>1 | 0 (0) |
NA | 1 (4) |
Stage | |
I/II | 17 (65) |
III/IV | 8 (31) |
NA | 1 (4) |
Bulky disease | |
Yes | 8 (31) |
No | 16 (62) |
NA | 2 (7) |
IPI | |
0-2 | 17 (65) |
3-5 | 5 (19) |
NA | 4 (16) |
IPS | |
0-1 | 9 (35) |
2-3 | 9 (35) |
4-6 | 2 (7) |
NA | 6 (23) |
LDH, lactate dehydrogenase; NA, not available.